Check here for more information about www.boehringer-ingelheim.com
Bosch Healthcare Solutions offers a worldwide unique combination: FeNO measurement in medical practice and at home.
FeNO measurement can significantly improve the diagnosis and therapy of asthma. Bosch Vivatmo measures the biomarker FeNO in exhaled breath simply and precisely. The Vivatmo system consist of: Vivatmo pro – the maintenance-free FeNO measurement device for use in practice and clinic and Vivatmo me – the world’s first FeNO home measurement device for patients and studies.
Bosch Healthcare Solutions GmbH is a wholly owned subsidiary of Robert Bosch GmbH which was established in 2015. The subsidiary’s solutions draw on the Bosch Group’s core competencies: sensors to collect data, software to evaluate that data, and services based on this data analysis. More information: www.bosch-healthcare.com, www.vivatmo-hcp.com
NIOX is dedicated to improving the diagnosis and management of respiratory diseases such as asthma. NIOX VERO®, the gold standard FeNO testing device, is accurate, reliable and easy-to-use by physicians and patients from the age of 4.
Our unique NIOX® technology is used by healthcare professionals worldwide to accurately assess Type 2 airway inflammation. FeNO testing is non-invasive and is performed in less than 2 minutes at the point-of-care. FeNO results support healthcare professionals to achieve more accurate diagnoses and better patient outcomes.